Mark Schembri
Professor of Microbiology
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Mark Schembri is a Professor of Microbiology at the University of Queensland, Australia. His research focuses on antimicrobial resistance, plasmid spread in gut microbiota, and the genetic mechanisms underlying bacterial resilience. Recent articles explore topics such as the impact of antidepressants on microbial behavior, the genomic surveillance of uropathogens, and strategies to support early-career microbiologists. His work contributes significantly to understanding microbial interactions and the evolution of resistance in clinically relevant pathogens.
Articles (18)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion transporter required for epithelial homeostasis in the lung and other organs, with CFTR mutations leading to the autosomal recessive genetic disease CF. Apart from excessive mucus accumulation and dysregulated inflammation in the airways, people with CF (pwCF) exhibit defective innate immune responses and are susceptible to bacterial respiratory pathogens such as Pseudomonas aeruginosa . Here, we investigated the role of CFTR in macrophage antimicrobial responses, including the zinc toxicity response that is used by these innate immune cells against intracellular bacteria. Using both pharmacological approaches, as well as cells derived from pwCF, we show that CFTR is required for uptake and clearance of pathogenic Escherichia coli by CSF-1-derived primary human macrophages. CFTR was also required for E. coli -induced zinc accumulation and zinc vesicle formation in these cells, and E . coli residing in macrophages exhibited reduced zinc stress in the absence of CFTR function. Accordingly, CFTR was essential for reducing the intramacrophage survival of a zinc-sensitive E. coli mutant compared to wild-type E. coli . Ectopic expression of the zinc transporter SLC30A1 or treatment with exogenous zinc was sufficient to restore antimicrobial responses against E . coli in human macrophages. Zinc supplementation also restored bacterial killing in GM-CSF-derived primary human macrophages responding to P. aeruginosa , used as an in vitro macrophage model relevant to CF. Thus, restoration of the zinc toxicity response could be pursued as a therapeutic strategy to restore innate immune function and effective host defense in pwCF.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Collaborators (19)
Mikael Boden
Associate Professor
University of Queensland
Nicholas Rattray
University Of Strathclyde
David Paterson
Professor
National University of Singapore (NUS)
Matthew J. Sweet
University of Queensland
James P. R. Connolly
-
Kate Schroder
University of Queensland
Leah Wendy Roberts
Queensland University of Technology
Ulrike Kappler
University of Queensland
Michael Landsberg
Senior Lecturer
University of Queensland
Sohinee Sarkar
Murdoch Childrens Research Institute
Jianhua Guo
Professor, Deputy Director
University of Queensland
Horst Joachim Schirra
Associate Professor
Griffith University
Nicky O'Boyle
University College Cork
Bostjan Kobe
Professor
University of Queensland
Luke Allsopp
Lecturer in Bacteriology
Imperial College London
Bart J. Currie
Charles Darwin University
Andrew J. Roe
-
Simon Williams
Senior Lecturer - ARC Future Fellow
Australian National University
Ross McGeary
Associate Professor
University of Queensland
Make your next move.
Prepare your application
Review drafts before you send them.